Variant report
Variant | esv3433984 |
---|---|
Chromosome Location | chr9:104606687-104607027 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530169325 | chr9:104606713-104606714 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549957891 | chr9:104606720-104606721 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs4742830 | chr9:104606728-104606729 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs1337688 | chr9:104606734-104606735 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552545722 | chr9:104606736-104606737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144530911 | chr9:104606746-104606747 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs577335106 | chr9:104606747-104606748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10819999 | chr9:104606759-104606760 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs568139371 | chr9:104606804-104606805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537191604 | chr9:104606806-104606807 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs553654784 | chr9:104606826-104606827 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557185594 | chr9:104606846-104606847 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572282851 | chr9:104606850-104606851 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112149860 | chr9:104606863-104606864 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570620021 | chr9:104606864-104606865 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs539624987 | chr9:104606884-104606885 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs552966352 | chr9:104606899-104606900 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185907903 | chr9:104606913-104606914 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562879409 | chr9:104606920-104606921 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs370773784 | chr9:104606934-104606935 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541054345 | chr9:104606944-104606945 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs57226682 | chr9:104606954-104606955 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530207268 | chr9:104606965-104606966 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574580540 | chr9:104606973-104606974 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Medulloblastoma | 21979893 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Myelofibrosis | 22110671 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Leukemia | 17361228 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Glioblastoma | 16823260 | CNVD |
Leukemia | 18688285 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Brain cancer | 20823417 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Heart disease | 21282601 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Lung cancer | 18438408 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Oral cancer | 21386901 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Prostate cancer | 18632612 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Gastric cancer | 17908304 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Cardiac fibroma | 18329553 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Fukuyama congenital muscular dystrophy | 21572526 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:104604200-104610200 | Weak transcription | K562 | blood |
2 | chr9:104606600-104607200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr9:104606800-104607400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |